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The unique, well-demarcated expression domain of Pdx1 within the posterior foregut suggests that investigating its transcriptional regulation
will provide insight into mechanisms that regionally pattern the endoderm. Previous phylogenetic comparison identified conserved noncoding
regions that stimulate transcriptional activity selectively in cultured pancreatic β cells. Characterization of these regulatory elements is helping to
dissect the transcription factor networks that operate within β cells, which is important for understanding the etiology of β cell dysfunction and
diabetes, as well as for developing methods to produce β cells in vitro for cell-based therapies. We recently reported that deletion of three
proximally located conserved areas (Area I-II-III) from the endogenous Pdx1 locus resulted in severely reduced expression of Pdx1 in the
pancreas, and a milder decrease in other foregut tissues. Here, we report transgene-based complementation experiments on Pdx1 null mice, which
reveal that the proximal promoter/enhancer region, including Area I-II-III, rescues the pancreatic defects caused by Pdx1 deficiency, but only
weakly promotes expression of Pdx1 in the postnatal stomach and duodenum. These results reveal a role for distal cis-regulatory elements in
achieving the correct level of extra-pancreatic Pdx1 expression, which is necessary for the production of duodenal GIP cells and stomach gastrin
cells.
© 2006 Elsevier Inc. All rights reserved.Keywords: Pancreas; β Cell; Foregut development; Enteroendocrine; Pdx1; Ipf1; Transcription factor; cis-RegulationIntroduction
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doi:10.1016/j.ydbio.2006.07.020endocrinology for more than a decade because of its essential
role in pancreas morphogenesis and involvement in heritable
Type II diabetes (reviewed by McKinnon and Docherty, 2001;
Melloul, 2004; Melloul et al., 2002). Pdx1 is first detectable
only in the nascent pancreatic buds, but its expression very
rapidly expands to include the epithelial progenitors of the
antrum and pylorus of the stomach, the rostral duodenum, and
the common bile duct (Guz et al., 1995; Offield et al., 1996).
Pdx1 expression persists in all of these organs in the adult,
although at lower levels than during embryogenesis. While it
is also expressed at low levels in mature pancreatic acini and
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expressed in pancreatic β cells and is required for their
function and maintenance in adult animals (Ahlgren et al.,
1998; Holland et al., 2002, 2005).
Pdx1−/− mice do not form any mature pancreatic tissue,
although a few glucagon-expressing cells can be found in a
poorly differentiated cyst-like rudiment that evaginates from
the duodenum (Ahlgren et al., 1996; Jonsson et al., 1994;
Offield et al., 1996). The pancreas is the most severely
affected organ in Pdx1−/− mice, but abnormalities are present
in all of the organs that normally express Pdx1. Defects in the
stomach include drastic reduction in the number of gastrin-
producing enteroendocrine cells (Larsson et al., 1996) and
malformation of the gastroduodenal junction, which is
characterized by an abnormal transition between gastric and
duodenal epithelia and malformation of the pyloric sphincter,
often leading to pyloric stenosis and stomach dilation (Offield
et al., 1996). The rostral duodenum forms very few, if any,
submucosal Brunner's glands, contains reduced numbers of
glucose-dependent insulinotropic polypeptide (GIP)-, secretin-
and cholecystokinin (CCK)-expressing enteroendocrine cells,
has shorter and sparser villus structures, and lacks a functional
sphincter of Oddi, resulting in reflux from the duodenum into
the common bile duct (Fukuda et al., 2006; Jepeal et al., 2005;
Offield et al., 1996). The common bile duct is deficient in
formation of peribiliary glands and mucin-producing cells
(Fukuda et al., 2006).
Pdx1+/− mice have abrogated insulin secretion in response to
glucose, presumably because of the reduced expression of Pdx1
target genes including Glucokinase, Glucose transporter 2
(Glut2) and Insulin (Brissova et al., 2002). Humans who are
heterozygous for inactivating mutations in IPF1 (Insulin
Promoter Factor 1, the human homolog of Pdx1) develop a
heritable form of strong early-onset Type II diabetes known as
Maturity Onset Diabetes of the Young (MODY) Type 4
(Stoffers et al., 1997, 1998). In addition to IPF1/Pdx1 itself,
mutations in MODY families have been mapped to genes
encoding transactivators of the Pdx1 gene, Hnf1α, Hnf1β, and
NeuroD1/Beta2, as well as to Glucokinase and Hnf4α, which
are transcriptional targets of Pdx1 (reviewed by Bell and
Polonsky, 2001; Shih and Stoffel, 2001).
The essential roles of Pdx1 in glucose homeostasis and
endoderm patterning have prompted great interest in under-
standing the regulation of Pdx1 transcription. There is still a
very poor understanding of the interplay of inter- and intra-
cellular factors in driving pancreatic differentiation. Pdx1
provides a valuable entry point into dissecting these processes
because of its early, specific expression in the pancreas and its
critical roles in promoting pancreatic differentiation. Pdx1 has a
TATA-less promoter and transcription can initiate from multiple
sites ranging from approximately 90 to 130 bp upstream of the
translational start codon (Sharma et al., 1996). In keeping with
precedent, we refer to 91 bp upstream of the translational start
codon as the +1 position. Promoter deletion studies and DNase
hypersensitivity analysis led to the identification of proximal
(−2.6 kb to−1.9 kb in mouse) and distal (−5.67 kb to−6.2 kb in
rat) enhancer sequences in the 5′ region of the rodent Pdx1locus (Sharma et al., 1996, 1997; Wu et al., 1997). Sequence
alignment between mouse and human revealed three highly
conserved areas in the proximal enhancer region, referred to as
Areas I, II and III (Gerrish et al., 2000; Marshak et al., 2000), as
well as a more distal block of conservation (Area IV) (Gerrish
et al., 2004). Electrophoretic mobility shift assays (EMSA) and
chromatin immunoprecipitation (ChIP) have confirmed binding
of several endoderm or endocrine cell enriched transactivating
factors to these areas: Foxa2 (Areas I, II and IV), Hnf6 (I and
III), Hnf1 (I), L-Maf (II), Nkx2.2 (I and IV), Pax6 (II) and Pdx1
itself (I and IV) (Ben-Shushan et al., 2001; Gerrish et al., 2000,
2001, 2004; Jacquemin et al., 2003; Marshak et al., 2000;
Samaras et al., 2002, 2003; Sharma et al., 1997; Van
Velkinburgh et al., 2005; Wu et al., 1997).
Reporter gene expression in transgenic mice has shown
that Area II can promote expression specifically in β cells,
and that this effect is more robust in combination with Area I
(Samaras et al., 2002; Van Velkinburgh et al., 2005). Longer
genomic sequences overlapping Areas I, II and III promote
expression in the pancreas and duodenum (Gannon et al.,
2001; Stoffers et al., 1999), although expression in the duo-
denum appears to be limited to the crypts (Stoffers et al.,
1999), which contain progenitors for all of the duodenal
epithelial cell types. Area IV has not yet been shown to be
sufficient to promote tissue-specific gene expression in vivo,
but in vitro evidence in cell lines suggests that it promotes β-
cell-specific transcriptional activation synergistically with
Areas I and II (Gerrish et al., 2004).
The collective influence of Areas I, II and III was recently
evaluated in vivo by targeted deletion of the 1.2 kb of
sequence encompassing these three areas (referred to as Area
I-II-III) (Fujitani et al., 2006). Deletion of Area I-II-III from
both alleles of Pdx1 severely disrupted pancreas morpho-
genesis, but the only extra-pancreatic abnormality that was
observed was a 50% reduction in stomach Gastrin cells and
duodenal GIP cells. Correspondingly, reduction in Pdx1
protein expression was more extreme in the pancreas than
in the stomach and duodenum. These results demonstrated the
necessity of Area I-II-III for pancreas development and robust
expression of Pdx1, but did not test if Area I-II-III is
sufficient to establish the correct spatiotemporal expression of
Pdx1.
To test the sufficiency of proximal cis-elements for correct
regulation of Pdx1 transcription, we used a transgene containing
the Pdx1 coding region and proximal regulatory regions to
attempt to rescue the pancreatic, stomach and duodenal
phenotypes in Pdx1−/− mice. A previous study demonstrated
rescue of the pancreatic phenotype of Pdx1−/− mice using a
transgene that included sequences extending 5′ through Area
IV, but the extra-pancreatic expression and activity of Pdx1 was
not examined in that study (Gannon et al., 2001). For the current
study, Area IV sequence was excluded from the rescue
transgene to test for distinct roles of proximal and distal
promoter elements, and the ability of the transgene to rescue
pancreatic and extra-pancreatic Pdx1 expression and activity
was evaluated. We carried out a detailed analysis of Pdx1
distribution and levels from E12.5 through 8 months of age, and
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glucose tolerance and enteroendocrine cell number. We find that
expression of Pdx1 encoded by the transgene is sufficient to
rescue pancreas morphogenesis and function, but that the
transgene does not support normal levels of extra-pancreatic
Pdx1 expression. Pdx1 expression from the transgene was
particularly weak in postnatal duodenum, and was associated
with a 90% reduction in the number of GIP-expressing cells
without other evident defects in morphology or differentiation
of the duodenum.
Materials and methods
Generation of 12.5-kb rescue transgene
A 14.5-kb genomic clone (Offield et al., 1996) was XbaI/BamHI digested to
generate a fragment from an XbaI site at −4.5 kb to the first intronic BamHI site.
BamHI/SalI digestion of the 14.5-kb clone gave a fragment from the second
intronic BamHI site to a SalI site in the 3′ λ linker. These fragments were
inserted into XbaI/SalI-restricted pBluescript KSII (Stratagene), and the
resulting plasmid digested with NotI/SalI. The insert was gel-purified, and
transgenic founders generated (Vanderbilt Transgenic Mouse/ES Cell Shared
Resource) by pronuclear injection into fertilized B6D2 oocytes, which were
transferred to pseudopregnant ICR females. F1 offspring and subsequent
generations were screened by genomic Southern blot (Supplemental Fig. 1).
Mouse strains and genotyping
The Pdx1 null allele used herein (XBko allele; Offield et al., 1996) is
designated Ipf1tm1Cvw by The Jackson Laboratory. The rescue transgene
eliminated 5 nt between two intronic BamHI sites and left a single site. In
XBko, sequences 3′ of the first intronic BamHI site are replaced by a NeoR
cassette. An oligonucleotide matching the genomic sequence that spans the
paired BamHI sites anneals to the wild-type allele but not the transgene or
XBko. Absence of PCR product with this primer was diagnostic for miceFig. 1. 12.5-kb transgene rescues pancreas formation in Pdx1−/− mice. (A) Schematic
mouse conservation are indicated by colored boxes (I–IV) after Gerrish et al. (2000
4.5 kb 5′ of the transcription start site to a SalI site introduced 3 kb 3′ of the stop codo
(Sc), BamHI (B), SmaI (Sm), SalI (S). (B–D) Dissected and fixed stomach (sto), sple
mature pancreatic tissue was present in Pdx1−/− pups. (D) Complementation of Pdxhomozygous for the XBko null allele. Transgene presence was subsequently
determined by Southern blot analysis on the same DNA samples. All mice
were maintained on a B6D2 mixed-inbred background. Experiments were
performed in accordance with the guidelines of the Vanderbilt University
IACUC.
Histology
Dissected tissues were fixed in 4% paraformaldehyde/PBS (3–5 h, 4°C; 1 h
for E12.5 embryos). Tissues were then dehydrated in an ethanol series, washed
into Histo-Clear (National Diagnostics) and paraffin-embedded. 5-μm sections
were cut using a Leica RM2135 microtome. PAS staining (Sigma) was
performed according to the manufacturer, and samples washed briefly in 10%
sodium metabisulfite to reduce background. Hematoxylin counterstain (Zymed)
was applied (30–90 s) to the desired intensity. Nuclear counterstain of anti-
villin-labeled sections was with YoPro-1 (1/1000 in PBS, Molecular Probes) for
20 min at RT. Pancreatic ducts were visualized by incubation for 1 h at RT with
rhodamine-labeled DBA-lectin (Vector) diluted 1/100 in 0.05% Triton X-100/
PBS. Immuno-detection of Pdx1 required antigen retrieval, which was
performed by heating to near-boiling (~100°C, 10 min; 10 mM sodium citrate,
pH 6.0). For immunohistochemistry, sections were incubated with primary
antibodies overnight at RT and with secondary antibodies for 2 h at RT. Details
of antibody concentrations and suppliers are provided in Supplemental Table 1.
All fluorescently labeled slides were mounted with ProLong Anti-fade Gold
reagent (Molecular Probes/Invitrogen).
Western blotting and quantification
Whole-pancreas nuclear extract was recovered as described by Gannon et al.
(2001). 10 mg protein/lane was run on NuPAGE 10% Bis–Tris gels (Invitrogen)
and transferred to Immobilon-P PVDF (Millipore). Membranes were blocked
(1 h, RT) in TBSMT (Tris-buffered saline, 5% dried nonfat milk, 0.1% Tween-
20) and incubated overnight at 4°C with primary antibody solution (1/2000
rabbit anti-Pdx1 (Peshavaria et al., 1994), 1/10,000 rabbit anti-histone 2B
(Sigma) in TBSMT). Membranes were washed in TBST (TBSMT without
milk), incubated in secondary antibody (1/2000 goat anti-rabbit-HRP, Santa
Cruz Biotech; 1 h, room temperature), and washed in TBST. Membranes were
incubated in SuperSignal West Pico Chemiluminescent Substrate (Pierce) forof Pdx1 genomic region. Noncoding sequences >100 bp with >75% human-to-
). The transgene used for genetic complementation extended from an XbaI site
n. Restriction sites shown are EcoRV (RV), XbaI (X), PstI (P), BstEII (Bs), SacI
en (spl), pancreas (panc) and first duodenal loop (duo) of newborn mice. (C) No
1−/− with 12.5-kb transgene rescued pancreas formation.
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at optimum (sub-saturation) exposure by varying the time of exposure.
Integrated band intensity was corrected for background, and Pdx1 band
intensity was corrected for histone 2B loading. One selected Pdx1+/− sample
was loaded on every gel to ensure blot-to-blot signal intensity equivalence.
Intraperitoneal glucose tolerance test
Following a 16-h fast, dextrose (2 mg/g body weight) was injected
intraperitoneally, and blood glucose measured using a BD Logic glucose
monitor (Becton Dickinson).
Quantification of duodenal enteroendocrine cells
P7 mice were sacrificed, and the gut tube from the body of the stomach to
the duodenum/jejunum junction removed, fixed, and embedded as described
above. 5-μm sections were cut parallel to the long axis. For each sample, 5
groups of 3 adjacent sections were chosen based on roughly equal spacing
across the diameter of the duodenum, and were immunostained for GIP, Gastrin
and CCK. Images collected at 20× magnification captured 450×340-μm
microscopic fields. For each section, five fields evenly spaced between the
gastroduodenal junction and the base of the first loop of the duodenum
underwent quantification. DAB-stained cells were counted manually. Hema-
toxylin-stained nuclei were counted using Metamorph software (Molecular
Devices) with boundaries set manually to restrict the count to villus epithelium.
For each mouse, the total number of hormone-positive cells compared to theFig. 2. Pancreatic tissue of transgene rescue mice is well differentiated. (A–C) Sectio
counterstained with hematoxylin (purple), showing similar structure and distribution
type mice. (D–F) Labeling of acinar tissue for amylase (blue) and ducts by DBA-lec
rescue mice. Islets were visualized by anti-Pdx1 labeling (green). (G–I) Staining for P
rescue mice, but abnormally high expression in acinar cell nuclei in both transgenictotal number of villus epithelial nuclei provided the frequency of GIP-, Gastrin-
and CCK-expressing cells.
Microscopy
Brightfield images were photographed using an Olympus DP-70 digital
camera and Olympus BH-2 compound microscope. Fluorescent images were
captured using a Zeiss LSM 510 Meta confocal microscope.
Statistics
Sample means for pancreatic nuclear Pdx1 level and enteroendocrine cell
frequency were compared by two-tailed, unpaired Student's t-test assuming
unequal variance. The null hypothesis was rejected for P<0.05.Results
Construction of Pdx1 transgene lacking distal regulatory
elements
A 14.5-kb region of the Pdx1 locus was previously isolated
from a lambda phage mouse genomic library (Fig. 1A; Offield et
al., 1996). The fragment includes 6.4 kb of sequence 5′ of thens of splenic lobe of pancreas were stained for insulin and glucagon (brown) and
of endocrine and exocrine pancreatic components in transgene rescue and wild-
tin (red) indicated that these structures were properly differentiated in transgene
dx1 (brown) indicated similar expression in the islets of wild-type and transgene
lines. Tissues from 1-week-old mice. Scale bars, 100 μm.
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Breeding of transgenic mice carrying this 14.5-kb region showed
its sufficiency in rescuing pancreas formation and glucose
homeostasis in mice that were homozygous null at the
endogenous Pdx1 locus (Gannon et al., 2001). To investigate
the regulatory influence of Area I-II-III independent of Area IV,
we tested if excluding Area IV from the transgene would affect its
ability to rescue the foregut organogenesis defects in Pdx1−/−
mice. We removed sequences 5′ of an XbaI site located
approximately 4.5 kb upstream of the transcription start site,
producing a transgene that extended from 1.7 kb 5′ ofArea I-II-III
to 3 kb 3′ of the stop codon (Fig. 1A). Three F1 mice tested
positive for this 12.5-kb transgene by genomic Southern analysis.
Independent transgenic lines were established and bred onto a
Pdx1−/− background. Two of the three lines rescued pancreas
formation. The third line generated a slightly thicker pancreatic
rudiment than was seen in Pdx1−/− littermates, but Pdx1 was not
detectable by immunohistochemistry at postnatal day 6 (P6) in
this line (data not shown). Southern analysis indicated that both of
the rescuing lines contained single-site insertions of the transgene.
One line (referred to hereafter as b1Tg) contained approximately
5 copies of the transgene in a concatemer, while the other (b3Tg)
had 2 copies inserted head-to-tail (Supplemental Fig. 1).
Transgene complementation of Pdx1−/− rescues pancreas
morphology and function
For both active transgenic lines, the rescued pancreas
(Pdx1−/−;Tg) was equivalent in size and gross morphology toFig. 3. Normal islet morphology in transgene rescue mice. (A–C) Confocal immuno
Sections adjacent to panels (A–C) were analyzed for PP (green), somatostatin (red
surrounded by mantle of α, δ and PP cells. Nuclear Pdx1 was observed in all β cells a
tended to contain more α cells, which were often located more centrally in the islets
organization of endocrine cells. Some α and PP cells showed weak nuclear Pdx1 im
have more α, δ, and PP cells than (A, D), there was no consistent difference in islet co
old mice. Scale bar in panel F is 50 μm. Same magnification for all panels.wild type (Figs. 1B, D). Histological analysis indicated that
the organization and differentiation of acinar, duct and
endocrine pancreatic tissues were very similar between wild-
type and transgene rescue mice (Figs. 2A–F). Immunohisto-
chemical staining for Pdx1 revealed that its expression was
higher than normal in acinar cell nuclei of both transgenic
lines, although the intensity of staining was still much higher
in islets than in acinar cells (Figs. 2G–I). Anti-Pdx1 staining
appeared to be slightly weaker than wild type in the islets of
Pdx1−/−;b3Tg mice and slightly stronger than wild type in
Pdx1−/−;b1Tg.
Because previous studies have shown that perturbation of
Pdx1 expression affects the composition and architecture of the
islets (Ahlgren et al., 1998; Fujitani et al., 2006; Johnson et al.,
2003), we examined the expression of Pdx1 and the islet
hormones at 3 months (Fig. 3) and 8 months (not shown) of age.
Some islets in Pdx1+/− mice showed modest infiltration of
glucagon-producing cells into the interior (Fig. 3B) and co-
expression of somatostatin and pancreatic polypeptide (PP)
(yellow cells, Fig. 3E). These abnormalities were not found in
Pdx1−/−;Tg mice (Figs. 3C, F), nor in Pdx1+/−;Tg mice (not
shown). The only apparent difference between wild-type and
transgenic islets was that we observed co-expression of Pdx1
with glucagon or PP in a few cells of each transgenic islet
examined (Figs. 3C, F, white arrowheads), while co-expressing
cells were not evident in most wild-type islets. Co-expression of
Pdx1 with glucagon and PP was also seen in Pdx1+/+;Tg and
Pdx1+/−;Tg mice (not shown). These results suggest that
regulatory elements missing from the transgene may help tofluorescence analysis for insulin (green), glucagon (red) and Pdx1 (blue). (D–F)
) and Pdx1 (blue). (A, D) Stereotypical wild-type islet structure: core β cells
nd most δ cells, but very rarely in α or PP cells. (B, E) Islets from Pdx1+/− mice
. (C, F) Islets from transgene rescue mice contained normal numbers and spatial
munoreactivity (arrowheads). Although the islet sections shown in panels (C, F)
mposition between transgene rescue and wild-type mice. Tissues from 3-month-
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(α) and PP cells. Induction of insulin expression was not
observed in the α cells that ectopically expressed Pdx1.
To assess the function of the rescued islets, mice were
subjected to intraperitoneal glucose tolerance testing (IPGTT)
using wild-type littermates as controls. In agreement with
previous reports (Brissova et al., 2002; Dutta et al., 1998;
Johnson et al., 2003), Pdx1+/− mice at 5–6 weeks and 5 months
of age experienced higher peak blood glucose levels and slower
glucose clearance than wild-type littermates (Figs. 4A, B).
Presence of b3Tg (Fig. 4A) or b1Tg (Fig. 4B) restored wild-type
glucose tolerance to Pdx1+/− mice, but Pdx1−/−;Tg micedisplayed intermediate glucose clearance curves between wild
type and Pdx1+/−.
Pdx1−/−;b1Tg mice are glucose intolerant despite abundant
Pdx1 protein
Several studies have shown a correlation between reduced
Pdx1 expression and glucose intolerance (e.g., Ahlgren et al.,
1998; Brissova et al., 2002; Gannon et al., 2001; Holland et al.,
2002, 2005). We postulated, therefore, that the intermediate
IPGTT performance of Pdx1−/−;Tg animals corresponded to an
intermediate level of Pdx1 protein in the pancreas. Based on
immunohistochemical analysis (Figs. 2G–I), the level of Pdx1
protein in islets of Pdx1−/−;b3Tg mice appeared to be slightly
lower than wild type, while that in Pdx1−/−;b1Tg mice was
slightly higher than wild type. To obtain a more quantitative
assessment of the level of Pdx1 expression in the transgene
rescue mice, we measured the amount of Pdx1 protein in
pancreatic extracts by densitometric analysis of Western blots.
By normalizing band intensity to that of a constitutively
expressed nuclear protein, histone 2B, we calculated the amount
of nuclear Pdx1 in heterozygotes to be approximately 43% of
wild-type levels in 3-month-old littermates (Fig. 4C). Western
blot analysis of b3Tg yielded results consistent with our
prediction: the Pdx1−/−;b3Tg mice had protein levels between
Pdx1+/− and wild type (∼56% of wild type). However, the level
of Pdx1 was at least twice that of wild type for all mice carrying
b1Tg (Fig. 4C). Overexpression in acinar tissue may have
contributed to the high level of Pdx1 in b1Tg mice, but the level
of Pdx1 in the islets of Pdx1−/−;b1Tg was also higher than in wild-
type mice (Fig. 2). It seems unlikely, therefore, that glucose
intolerance in Pdx1−/−;b1Tg mice resulted from an insufficient
level of Pdx1 in mature β cells. In addition, the lack of glucose
intolerance in Pdx1+/−;b1Tg mice suggested that overexpression
of Pdx1 in acinar, α, and PP cells did not significantly impair
islet function. We have yet to decipher the underlying cause of
glucose intolerance in the transgene rescue mice, but reduced
production of duodenal incretins, or minor perturbation of islet
development, may be contributing factors (see Discussion).Fig. 4. Comparison of IPGTT and pancreatic Pdx1 content among offspring of
Pdx1+/−;Tg parents. (A) Offspring of Pdx1+/−;b3Tgmice; 5 litters of 5–6 weeks of
age. Glucose tolerance of Pdx1+/− mice (white) was impaired compared to wild
type (black). Pdx1−/−;b3Tg (yellow) had a mild impairment, while glucose
tolerance of Pdx1+/−;b3Tg (orange) and Pdx1+/+;b3Tg (red) was normal. Number
of each genotype: wild type (5), Pdx1+/− (10), Pdx1+/+;b3Tg (2), Pdx1+/−;b3Tg
(10), Pdx1−/−;b3Tg (8). (B) Offspring of Pdx1+/−;b1Tg mice; 4 litters, 5 months of
age. Glucose tolerance of Pdx1−/−;b1Tg mice (green) was intermediate between
wild type (black) and Pdx1+/− (white). Pdx1+/−;b1Tg (purple) and Pdx1+/+;b1Tg
(blue) were similar to wild type. Glucose tolerance for mice in panel B was
generally worse than in panel A because of age. Number of each genotype: wild
type (2), Pdx1+/− (11), Pdx1+/+;b1Tg (4), Pdx1+/−;b1Tg (9), Pdx1−/−;b1Tg (4). (C)
Nuclear proteins from whole pancreas of 3-month-old mice (genotype indicated;
color coding as for panels A and B). Relative Pdx1 level was determined based
on Western blot signal intensity with the average wild-type value set as “1”.
Anti-histone 2B immunoreactivity, loading control. P<0.05 for Pdx1+/−
versus all other genotypes. P<0.05 for wild type versus all genotypes
except Pdx1+/+;b3Tg. Number of each genotype: wild type (8), Pdx1+/− (9),
Pdx1+/+;b3Tg (3), Pdx1+/−;b3Tg (6), Pdx1−/−;b3Tg (6), Pdx1+/+;b1Tg (5),
Pdx1+/−;b1Tg (6), Pdx1−/−;b1Tg (4). Error bars in panels A–C indicate ±SEM.
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and stomach
We next characterized the developmental time-course of
Pdx1 expression from b1Tg and b3Tg to determine whetherproximal regulatory regions were sufficient for normal spatio-
temporal expression of Pdx1 during development. Breeding the
12.5-kb transgene onto a Pdx1−/− background (the “XBko”
allele (Offield et al., 1996) from which no protein product is
detectable, e.g., Fig. 6D) ensured that the only Pdx1 protein
623D.F. Boyer et al. / Developmental Biology 298 (2006) 616–631detected was transgene-encoded. No consistent differences in
Pdx1 expression were observed after side-by-side preparation
and staining of tissues from wild-type and Pdx1−/−;Tg embryos
from E12.5 and E16.5 (Figs. 5A, B, D, E), indicating that
relatively proximal sequences are indeed sufficient to mediate
the proper timing and distribution of embryonic Pdx1 expres-
sion. In addition, immunostaining for glucagon, insulin and
amylase indicated that pancreatic tissues were properly
differentiated in transgene rescue embryos at these stages
(Supplemental Fig. 2).
In contrast to the normal spatiotemporal expression observed
during embryogenesis, the 12.5-kb transgene was not sufficient
for normal levels of expression in postnatal duodenum. In
neonatal (P0) mice, expression of Pdx1 was much weaker in the
duodenal epithelium of Pdx1−/−;Tg mice as compared to wild-
type littermates, but pancreatic expression was not appreciably
different (Figs. 5C, F). Reduced duodenal Pdx1 expression was
observed in both transgenic lines and persisted throughout
adulthood (Figs. 5G–N), although the level of transgenic Pdx1
expression was consistently lower in b3Tg than in b1Tg mice
(cf., Figs. 5J, M). Pdx1 expression was not substantially
reduced in the submucosal Brunner's glands that cuff the
rostral-most portion of the duodenum (Figs. 5H, K).
Pdx1 immunoreactivity was substantially weaker than
wild-type or Pdx1+/− levels in the mucosal epithelium of all
Pdx1−/−;Tg duodena examined from both transgenic lines.
There was, however, some variability in the level and pattern
of duodenal Pdx1 expression among transgene rescue mice of
identical genotype. Also, most of the Pdx1−/−;Tg mice from
both lines showed a variable intensity of Pdx1 staining along
the duodenal epithelium. In general, Pdx1 was more strongly
expressed in crypts than in villi (e.g., Fig. 5J), although the
level of expression varied among neighboring crypts (e.g.,
Figs. 5K, 9C). Ribbons of relatively high-expressing cells
were frequently observed extending up the proximal villi
associated with the more strongly expressing crypts, con-
sistent with the progenitor-daughter relationship between the
surrounding crypts and their derived villus epithelial cells. In
wild type and Pdx1+/− mice, Pdx1 appeared to be expressed
at equal levels in all crypts and villi of the rostral portion of
the duodenum, although the intensity of immunostaining
often appeared stronger at the bases of the villi than at their
tips. We hypothesize that a variegated expression pattern is
observed in Pdx1−/−;Tg duodenal epithelium because an
abnormally low level of Pdx1 transcription in postnatal crypt
stem cells exacerbates the influence of stochastic transcriptionalFig. 5. Developmental profile of Pdx1 expression in Pdx1−/−;Tg compared to wild
during embryonic stages. The extent of expression in the stomach appeared to be
of section. No difference in expression in the stomach was seen at E16.5. Repr
VP, ventral pancreatic bud; DP, dorsal pancreatic bud; Du, duodenum; St, stom
observed in Pdx1−/−;Tg duodena (Pdx1−/−;b3Tg shown in panel F). (G–M) Du
postnatally. Representative sections: Pdx1−/−;b1Tg (J) and Pdx1−/−;b3Tg (K, L, M).
Pdx1−/−;b3Tg (M) than in Pdx1−/−;b1Tg (J). Both were much weaker than Pdx1+/−
similar among the different genotypes. (H, K) 3 months of age, sections of duode
that was relatively well-preserved in Brunner's glands (Br), variable in crypts (Cr)
nuclei in Brunner's glands. All tissues from each stage were processed, stained a
panels F, G, J, N indicate islet tissue. Scale bars, 200 μm. Same magnification factivation (i.e., “transcriptional noise”). This leads to the
production of a low, but variable, level of Pdx1 protein in
basal enterocytes that is gradually lost as they ascend the villi.
The 12.5-kb transgene also failed to provide full expression
of Pdx1 in the antropyloric mucosa of the postnatal stomach
(Figs. 6A–D). Detection of Pdx1 was rather weak even in wild-
type stomach at P7 but was more readily detected at 3 months of
age, at which time the difference in immunoreactivity between
wild type and Pdx1−/−;b3Tgwasmore pronounced (Supplemental
Figs. 3A, B). In wild-type P7 mice, Pdx1 was detectable in all
antropyloric epithelial cells with scattered cells staining much
more intensely for Pdx1 (Fig. 6A). In Pdx1−/−;b1Tg mice, the
scattered high-expressing cells were still readily detected, but the
overall level of Pdx1 appeared to be lower (Fig. 6B). As in the
pancreas and duodenum, the level of expression from b3Tg was
less than from b1Tg. Although scattered cells in Pdx1−/−;b3Tg
stomach had higher levels of Pdx1 expression, their immunos-
taining intensity was still weaker than wild type (Fig. 6C).
Consistent with previous reports (Fujitani et al., 2006; Larsson et
al., 1996), expression of gastrin in the antropyloric mucosa was
undetectable in P7 Pdx1−/− mice (Fig. 6H). The number of
gastrin cells appeared to be slightly fewer than wild type in
Pdx1−/−;b1Tg and was substantially reduced in Pdx1−/−;b3Tg at
P7 (Figs. 6E–G). The number of somatostatin cells in the
stomach was not reduced in Pdx1−/− or in transgene rescue
mice (Supplemental Figs. 3C–F).
Well-differentiated duodenum in Pdx1−/−;Tg mice
To assess the phenotypic consequences of reduced Pdx1
expression in the duodenum, we compared morphology and
marker expression inwild-type,Pdx1+/−,Pdx1−/− andPdx1−/−;Tg
mice. Pdx1+/−mice were indistinguishable fromwild type for all
of the criteria examined, and for simplicity are therefore omitted
from Fig. 7. While the transformation from a pseudostratified
epithelium to the initial crypt-villus architecture occurs over a
relatively shortperiod towards theendofgestation, thematuration
of the duodenum continues significantly after birth. Over the first
few weeks of life there is a thickening of the muscular wall of the
duodenum, increased crypt depth, increased numbers of enter-
oendocrine cells, and proliferation of Brunner's glands. Our
analysis focusedonP7micebecause itwas the latest stageatwhich
Pdx1−/− pups could consistently be recovered. The major
anatomical features of the duodenum, i.e., the crypts, villi and
submucosal Brunner's glands, were all present in Pdx1−/− pups,
but the villi tended to bemuch shorter and sparser than wild type,type. (A, B, D, E) Pdx1 expression in Pdx1−/−;Tg was similar to wild type
reduced in Pdx1−/−;Tg at E12.5, but this may be an artifact due to the plane
esentative sections, Pdx1−/−;b1Tg at e12.5 (D) and Pdx1−/−;b3Tg at e16.5 (E).
ach; Pa, pancreas. (C, F) After birth, reduced Pdx1 immunoreactivity was
odenal Pdx1 expression continued to be substantially lower in Pdx1−/−;Tg
(G, J, M, N) One week of age. Duodenal Pdx1 expression was weaker in
(N) or wild type (G). The intensity of Pdx1 staining in pancreatic tissue was
num near the gastroduodenal junction showed Pdx1 expression in Pdx1−/−;Tg
and weakest in villi (Vi). Insets in panels H, K, higher magnification of Pdx1+
nd photographed side-by-side under the same conditions. Dotted outlines in
or all panels except (B, E).
Fig. 6. Concordant reduction in Pdx1 and gastrin in stomach at P7. (A–D) Immunoperoxidase staining for Pdx1 in the antropyloric mucosa showed progressive
reduction in intensity from wild type to Pdx1−/−;b1Tg to Pdx1−/−;b3Tg, and no staining in Pdx1−/−. (E–H) Frequency of gastrin-immunopositive cells (brown) showed a
similar correlation to genotype. Immunoperoxidase-DAB, hematoxylin counterstain. Scale bars, 100 μm. Same magnification for all panels.
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greatlyreduced innumberandwerepoorlydifferentiatedbasedon
morphology and PAS staining (Fig. 7H). These defects were not
found inPdx1−/−;Tgmice (Figs. 7C, F, I) representing either the b1
or b3 lines.
The predominant duodenal epithelial cell is the enterocyte,
which was confirmed to be present in wild-type and mutant
animals by its apical villin (Figs. 7A–C). The villus epitheliumalso contains mucous-secreting goblet cells, stained by the PAS
method (Figs. 7D–F), and hormone-producing enteroendocrine
cells, identified by production of chromogranins (Figs. 7J–L).
While the frequency of goblet cells appeared unchanged in the
Pdx1−/− mutants, the number of epithelial cells expressing
chromogranins appeared lower, consistent with previous reports
of reduced enteroendocrine cell populations in these mutants
(Jepeal et al., 2005; Larsson et al., 1996; Offield et al., 1996).
Fig. 7. Well-differentiated duodenal epithelium in Pdx1−/−;Tg mice at P7. (A–C) Apical villin expression (red), characteristic of differentiated enterocytes in wild type,
Pdx1−/− and Pdx1−/−;Tg mice (nuclei detected with YoPro-1, green). (D–F) PAS-stained goblet cells (magenta; hematoxylin counterstain) were present at similar
frequencies in wild type, Pdx1−/− and Pdx1−/−;Tg mice. Villi in Pdx1−/− had a ragged appearance not observed in Pdx1−/−;Tg. (G–I) Number, elaboration and mucin
content of Brunner's glands was greatly reduced in Pdx1−/−, but normal in Pdx1−/−;Tg. Staining as in panels D–F. (J–L) Immunoperoxidase-DAB staining of
chromogranins (brown; hematoxylin counterstain) indicated enteroendocrine cells (arrows) in wild type, Pdx1−/− and Pdx1−/−;Tg duodena. Scale bars, 100 μm.
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between Pdx1−/−;Tg and wild-type pups. Because the presence
of specific enteroendocrine hormone-producing cells is differ-
entially sensitive to the loss of Pdx1 (Jepeal et al., 2005;
Larsson et al., 1996; Offield et al., 1996), we analyzed our
transgene rescue mice for cells producing gastrin, GIP, and
CCK.
GIP cell number is exquisitely sensitive to the level of Pdx1
The number of GIP cells in the rostral duodenum is
profoundly reduced in Pdx1−/− mice (Jepeal et al., 2005), anddeletion of Area I-II-III revealed that low levels of Pdx1
during embryogenesis resulted in dose-dependent reduction in
the number of GIP cells at E18.5 (Fujitani et al., 2006). In
contrast to mice with Area I-II-III deletion, the duodenum of
transgene rescue mice showed normal levels of Pdx1 during
embryogenesis, but markedly reduced postnatal expression.
We quantified the number of GIP-expressing cells to evaluate
whether postnatal maintenance of the GIP cell population
required sustained expression of Pdx1. Gastrin- and CCK-
producing cells were included in the quantitative analysis
because they have been shown to be decreased in Pdx1−/−
mice (Larsson et al., 1996; Offield et al., 1996).
Fig. 8. Frequency of enteroendocrine cells in duodenum at P7. The number of
GIP, gastrin and CCK cells relative to the total number of duodenal epithelial cell
nuclei was determined in longitudinal sections of duodenum from wild-type
(n=5), Pdx1+/− (n=5), Pdx1−/−;b1Tg (n=4), Pdx1−/−;b3Tg (n=4) and Pdx1−/−
(n=3) mice (see Materials and methods for details). Crosses indicate values for
individual mice, bars the mean of each group. (A) The frequency of GIP cells
varied by genotype in accordance with the relative level of Pdx1 expression
observed (Fig. 5). P<0.05 for Pdx1−/−;b1Tg, Pdx1−/−;b3Tg and Pdx1−/− compared
to wild type. (B) Gastrin cell frequency in the duodenum was reduced to varying
degrees in Pdx1−/− mice but was similar among mice of the other genotypes
examined. P<0.05 for Pdx1−/− compared to wild type. (C) CCK cell frequency
was significantly reduced only in Pdx1−/− (P<0.05) but appeared to follow a
slight downward trend paralleling the relative levels of Pdx1 shown in Fig. 5.
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reduced by approximately 50% in Pdx1−/−;b1Tg, and 90% in
Pdx1−/−;b3Tg mice (Fig. 8A). No GIP-expressing cells were
identified in extensive sampling of rostral duodena from three
Pdx1−/− mice. A slight, but statistically insignificant, reduc-
tion in GIP cell frequency was found in Pdx1+/− mice
compared to wild type. The trend of GIP cell frequency
among the five genotypes correlated well with the intensity of
Pdx1 immunostaining on duodenal sections processed side-
by-side under identical conditions (Figs. 5G, J, M, N),
suggesting that Pdx1 has a dose-dependent influence on the
postnatal generation of GIP-producing cells. The frequencies
of gastrin- and CCK-expressing cells were reduced in Pdx1−/−
mice by approximately 57% and 60% respectively, but were
not significantly affected in mice of the other genotypes (Figs.
8B, C). The 25% reduction in CCK cell frequency observed
in Pdx1−/−;b3Tg mice compared to wild type had a P value
between 0.1 and 0.05 by t-test analysis, suggesting that the
reduction was correlated with the transgene rescue genotype.
In summary, duodenal GIP, gastrin and CCK cells were
reduced in Pdx1−/− mice at P7, but a strong dose-dependent
effect of Pdx1 was found for GIP only. We also observed a
dose-dependent influence of Pdx1 on antropyloric gastrin cells
(Fig. 6). The specific effect of postnatal Pdx1 dosage on
duodenal GIP and antropyloric gastrin cells is consistent with
our previous analysis of Pdx1 dosage effects (Fujitani et al.,
2006).
Temporal and spatial correlation of Pdx1 and enteroendocrine
hormone expression
To determine if the reduction in duodenal GIP and
stomach gastrin cells was temporally synchronized to the
postnatal reduction in Pdx1 expression in the transgene
rescue mice, GIP and gastrin expression were examined at
E16.5 and P0 (Supplemental Fig. 4). At E16.5, gastrin
expression was detected in both stomach and duodenum in
wild-type, Pdx1−/−;b1Tg and Pdx1−/−;b3Tg mice. The same
distribution was observed at P0 for wild-type and b3Tg
mice. In Pdx1−/− mice, gastrin was detected in the
duodenum but not stomach at E16.5 or P0. These results
indicate that antropyloric gastrin cells form normally in Pdx1
−/−;Tg mice during late embryogenesis, when Pdx1 is still
robustly expressed in the posterior foregut, but the number
of gastrin cells decreases during the first week of life,
subsequent to the reduction of Pdx1 expression. GIP-
expressing cells were not detected in the rostral duodena
of any of the various genotypes at E16.5, and were only
found in wild type at P0 (note: b1Tg rescue mice were not
evaluated at P0). These data suggest that the initial formation
of GIP cells was impaired in Pdx1−/−;b3Tg mice, because the
time of appearance of GIP-expressing cells in wild-type mice
is similar to the stage when transgene rescue mice exhibit
decreased duodenal Pdx1 expression.
Previous studies showed that Pdx1 is expressed through-
out the rostral duodenal epithelium, declining caudally to a
punctate expression pattern (Offield et al., 1996). These
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crine cells, but to our knowledge this has not yet been
directly tested. Considering the evidence from the current
and previous studies for strong dependence of GIP cells on
Pdx1, we tested for co-expression of Pdx1 and GIP in the
caudal duodenum. All caudal GIP-producing cells had strong
Pdx1 immunoreactivity (e.g., Fig. 9B), while co-labeling for
Pdx1 and the general endocrine marker chromogranin A/B
revealed that the majority of endocrine cells in the caudal
duodenum expressed relatively low levels of Pdx1 (Fig. 9D).
These results are consistent with greater dependence of GIP
expression on Pdx1 as compared to other duodenal
enteroendocrine hormones. Because the duodenal epithelium
of Pdx1−/−;Tg mutants showed a low level of Pdx1
expression with considerable regional variability (e.g., Fig.
9C), we hypothesized that the remaining GIP cells in these
mice would be found in regions with relatively high Pdx1
expression. In contrast, however, GIP-producing cells with
little or no Pdx1 immunoreactivity were often observed in
Pdx1−/−;b3Tg mice, and adjacent Pdx1 high- and low-
expressing regions showed no noticeable difference in the
frequency of GIP-expressing cells (Fig. 9C). Chromogranin-
positive cells also appeared equally abundant regardless of
the level of Pdx1 expression (Fig. 9E). We conclude that
while wild-type GIP cells express a relatively high level of
Pdx1, and wild-type levels of Pdx1 are required to produce
the normal number of GIP cells, GIP hormone can still be
produced by cells expressing a low level of Pdx1.Fig. 9. Comparison of Pdx1 expression and enteroendocrine cell distribution in mat
(red), or (D, E) Pdx1 (green) and chromogranins (red). (A) In rostral wild-type duoden
type duodenum, Pdx1 expression was weaker with isolated strongly immunopositive
relatively strong Pdx1 expression. Background in the red channel (including RBC au
was increased to detect weak GIP labeling. (D) Some chromogranin-expressing cells i
did not. Some Pdx1 high expressers did not co-label for chromogranins (blue arro
duodenum did not appear to influence the distribution of GIP cells (C) or of enteroen
Pdx1- and chromogranin-positive. All sections from 8-month-old mice. Yellow arrow
undetectable Pdx1 expression. Scale bars, 100μm.Discussion
Proximal sequences sufficient for pancreatic Pdx1 expression
The studies described above indicate that cis-acting
elements within 12.5 kb surrounding and including the Pdx1
coding sequence are sufficient to regulate most aspects of Pdx1
gene expression in the pancreas. Expression of Pdx1 from the
12.5-kb transgene recapitulated the normal spatiotemporal
expression profile of Pdx1 and supported full pancreatic
morphogenesis, specification of all endocrine islet cells in
properly organized islets, and glucose-stimulated insulin
secretion from mature β cells. One possibility to explain the
increased expression of Pdx1 in most pancreatic acinar cells
and some α and PP cells is that the transgene lacks regulatory
elements that suppress expression of Pdx1 in non-β cells in the
mature pancreas.
The only noncoding regions in the transgene with at least
100 bp of greater than 75% conservation between mice and
humans are the previously identified Areas I, II and III, which
reside within the 4.6 kb of 5′ noncoding sequence (Fig. 1A).
The sufficiency of this region to regulate most aspects of Pdx1
expression is consistent with lacZ-reporter expression profiling
experiments (Gannon et al., 2001; Stoffers et al., 1999), which
showed that the proximal 4.6-kb sequence (from the XbaI site at
−4.5 kb to the translational start codon) mediated expression
throughout the endogenous Pdx1 expression domain. The
pancreatic buds of our transgene rescue mice wereure duodenum. Immunofluorescence analysis for (A–C) Pdx1 (green) and GIP
um, all epithelial cells robustly expressed Pdx1. (B) In the caudal portion of wild-
epithelial cells. All of the GIP-expressing cells observed in the caudal region had
tofluorescence in the stromal tissue) is rather high in this panel because the gain
n caudal wild-type duodenum strongly expressed Pdx1 (yellow arrow), but many
w). (C, E) The variegated pattern of Pdx1 expression in mature Pdx1−/−;b3Tg
docrine cells in general (E). Pancreatic islet at lower edge of panel E is intensely
s, double-labeled cells. Purple arrows indicate enteroendocrine cells with low/
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4.6-kb promoter region is sufficient to initiate expression in the
full pancreatic progenitor population from early stages of
pancreas development. Although the rescue transgene was
sufficient to mediate the proper spatiotemporal expression of
Pdx1 in embryonic gut epithelium, it did not support robust
expression of Pdx1 in the postnatal stomach and duodenum.
Complementation phenotype consistent with enhancer deletion
results
Our recent findings (Fujitani et al., 2006) demonstrated that
mice homozygous for a targeted deletion of the Area I-II-III
enhancer region had severely impaired pancreas development,
but only mild defects in the duodenum and stomach. The
current findings are largely consistent with those results,
showing that complementation rescue of Pdx1−/− with a
transgene covering Area I-II-III is sufficient to support pancreas
development but only weakly promotes Pdx1 expression in
postnatal duodenum and stomach. One caveat to the enhancer
deletion study was that deletion of an enhancer region from the
Pdx1 locus might affect expression of neighboring genes, such
as Gsh1 and Cdx2 in the evolutionarily conserved Parahox gene
cluster (Brooke et al., 1998). By evaluating expression of Pdx1
from randomly integrated transgenes, we confirmed that
regulation of Pdx1 by proximal elements is sufficient for
pancreas morphogenesis, independent of other gene regulatory
events that may occur in the endogenous locus. Because both
lines that expressed detectable Pdx1 showed identical spatio-
temporal expression, it seems reasonable to conclude that the
expression pattern was specific to the regulatory elements
contained in the transgene sequence, and was not significantly
influenced by the site of transgene integration.
Transgene rescues glucose tolerance fully in Pdx1+/−, partially
in Pdx1−/−
Both transgenic lines were able to rescue the glucose
intolerance that results from heterozygosity at the endogenous
Pdx1 locus, and complementation of Pdx1−/− mice resulted in
glucose clearance that was intermediate between wild type and
Pdx1+/−. We were surprised to discover that the Pdx1−/−;b1Tg
mice were glucose intolerant despite producing higher levels of
Pdx1 than wild type. We have not yet been able to determine the
cause of glucose intolerance in these mice, but one possibility is
that the transgene rescue mice have a subtle defect in islet
development that results in a mildly abnormal glucose response
even when their β cells contain abundant Pdx1. Gap junction
connectivity between β cells and interactions between β cells
and the islet capillary network are important for islet function
(Rocheleau et al., 2006; Lammert et al., 2003). Subtle
abnormalities in the expression of Pdx1 in developing or
maturing islets might disrupt the proper establishment of these
interactions, resulting in impaired glucose tolerance. Another
possibility is that the impaired islet function is secondary to the
reduced number of GIP cells in the transgene rescue mice. GIP
has a well-characterized incretin effect enhancing the responseof β cells to glucose (reviewed by Drucker, 2006), such that
decreased GIP production in the transgene rescue mice may
limit the responsiveness of their β cells.
Mice that had both wild-type alleles of Pdx1 plus either
b1Tg or b3Tg (Pdx1+/+;Tg) produced supraphysiological levels
of pancreatic Pdx1. Neither of these genotypes had deleterious
effects on pancreatic development or function, nor was there
accelerated glucose clearance in the presence of excess Pdx1.
We conclude that the wild-type level of Pdx1 is required for
normal glucose clearance, but that excess Pdx1 does not
enhance the response of β cells to glucose challenge.
Proximal Pdx1 promoter elements express poorly in duodenum
Although both transgenic alleles produced more Pdx1 in the
pancreas than a single wild-type allele (i.e., Pdx1+/−), rescue of
Pdx1−/− with either transgenic allele resulted in much weaker
expression of Pdx1 in the duodenum than was observed for
Pdx1+/− mice (cf., Figs. 5J, M, N). The transgene rescue mice
also had reduced Pdx1 expression in the stomach, but the
reduction compared to the wild-type level was not as dramatic
as in the duodenum. Stoffers et al. (1999) examined expression
of a lacZ reporter driven by the 4.6 kb 5′ Pdx1 promoter region
and reported weak X-gal staining in the duodenal epithelium,
even though Pdx1 protein was readily detected by immunohis-
tochemistry. They speculated that weak X-gal staining in the
duodenum resulted from poor perdurance of β-galactosidase
after production in the crypts. Arguing against this reasoning,
however, mice heterozygous for a knock-in of lacZ into the
Pdx1 locus are X-gal positive throughout the epithelium of
the rostral duodenum (Offield et al., 1996). The difference in
duodenal expression between the knock-in and transgenic β-
galactosidase reporter alleles is consistent with the reduced level
of Pdx1 expressed from our 12.5 kb rescue transgene as
compared to the endogenous locus. These results suggest that
sequences upstream of −4.5 kb are required for full duodenal
expression.
Dose-dependent influence of Pdx1 on GIP and antral stomach
gastrin cells
The intensity of Pdx1 immunoreactivity indicated that b1Tg
produced more Pdx1 protein in the duodenum than b3Tg, but
less than Pdx1+/−. We were therefore able to analyze the
influence of a spectrum of Pdx1 protein levels in the duodenum:
Pdx1+/+ > Pdx1+/− > Pdx1−/−;b1Tg > Pdx1−/−;b3Tg > Pdx1−/−.
Interestingly, the frequency of GIP-expressing cells at 1 week of
age followed the same trend as the level of Pdx1 protein. GIP
has recently been shown to be a direct transcriptional target of
Pdx1, and expression of GIP is virtually absent from Pdx1−/−
duodenal epithelium (Jepeal et al., 2005). If Pdx1 was simply a
direct transactivator of the GIP gene, then reduced Pdx1 might
have resulted in the same number of GIP-expressing cells, but
each expressing less GIP. We observed, however, a 90%
reduction in the proportion of duodenal epithelial cells that
expressed GIP in the Pdx1−/−;b3Tg mice, suggesting that Pdx1
affects the frequency at which enteroendocrine progenitors
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of duodenal epithelial cells producing gastrin and CCK in the
transgene rescue mice was not significantly reduced compared
to wild type, although the number of these cell types is
substantially reduced in Pdx1−/− mutants. This suggests that a
relatively small amount of Pdx1 is sufficient for formation of
CCK and duodenal gastrin cells.
The number of gastrin cells in the stomach appeared to be
greatly reduced in Pdx1−/−;b3Tg mice despite a lack of
significant change in duodenal gastrin cell frequency. While
some gastrin cells were present in the duodena of Pdx1−/− mice,
stomach gastrin cells were undetectable at E16.5, P0 and P7 in
Pdx1−/− mice. The stricter dependence of antropyloric gastrin
cells on Pdx1 may reflect region-specific differences in the
progenitor cell populations in the stomach and duodenum.
Potential in vivo roles of Area IV
Among the previously characterized evolutionarily con-
served regions of Pdx1, Area IV is the only one not contained in
our transgene, making it an obvious candidate for the cis-
regulatory activity required for full expression of Pdx1 in the
duodenum and stomach. However, the factors that likely bind
within Area IV also bind within Areas I, II and III, and are
primarily expressed in endocrine pancreas (Fig. 10). Further-
more, in vitro analysis of Area IV activity suggested that it
functions in synergy with Areas I and II to promote β-cell-
specific transcription (Gerrish et al., 2004). The current findings
raise the possibility that Area IV may contain additional binding
sites for factors that are particularly important for transcription
in foregut crypt stem cells. Although the transgene providedFig. 10. Overview of transactivator interactions on Pdx1 5′ noncoding region. Top,
phylogenetic sequence conservation (Ben-Shushan et al., 2001; Gerrish et al., 2000,
2003; Sharma et al., 1997; Van Velkinburgh et al., 2005; Wu et al., 1997). “?”, Hyp
boxes indicate tissues where proximal or distal cis-regulatory regions seem to be o
proximal or distal region, respectively, indicate the stronger influence of proximal re
embryonic and adult locations of Pdx1 expression and its transactivators that are rep
Matsuoka et al., 2004; Naya et al., 1997; Rausa et al., 1997; Sander et al., 1997; Stnear-to or greater-than wild-type levels of Pdx1 protein in the
pancreas, these data do not rule out an in vivo role for Area IV in
enhancing pancreatic Pdx1 expression, or that the activity of
Area IV may be required under specific physiological demands.
For instance, the presence of tandem copies of the transgene in
the b1 and b3 lines may circumvent the requirement for synergy
between Area IV and Areas I and II. Another possibility is that
Area IV may contribute to regulation of Pdx1 during islet
development, and the absence of that regulatory influence in the
Pdx1−/−;Tg mice might explain the impairment of glucose
tolerance despite abundant Pdx1 in mature Pdx1−/−;b1Tg
pancreas. In support of this potential role of Area IV, previous
analysis of rescue of Pdx1−/− using a transgene that included
Area IV (Gannon et al., 2001) showed GTT performance that
appears to be closer to wild type than the current results using
the 12.5-kb transgene. We were unable to directly compare the
14.5 kb and 12.5-kb transgenes because the 14.5 kb transgenic
lines were not kept, and in any case we would be unable to
completely rule out position of transgene integration effects. We
plan to delete distal enhancer elements from the endogenous
Pdx1 locus, which will hopefully resolve these uncertainties.
Our recent examination of mouse and human Pdx1/IPF1
genomic sequence alignment using the Lawrence Berkeley
Laboratories online Vista browser (http://pipeline.lbl.gov)
revealed two additional regions of greater than 75% sequence
conservation within 5 kb upstream of Area IV and additional
conserved regions between Pdx1 and its nearest 5′-located
neighbor, the transcriptional regulator-encoding gene, Gsh1.
These as-yet uncharacterized conserved sequences may also
contribute to cis-activation of Pdx1 in the duodenum and
stomach.previously reported sites of protein–DNA interaction in relation to regions of
2001, 2004; Jacquemin et al., 2003; Marshak et al., 2000; Samaras et al., 2002,
othetical transactivator promoting expression in postnatal foregut. Middle, text
f particular importance for Pdx1 expression. “β Cells” in bold or grey for the
gions on β-cell-specific expression, from in vitro and in vivo evidence. Bottom,
orted as expressed in those tissues (Coffinier et al., 1999; Maestro et al., 2003;
-Onge et al., 1997; Sussel et al., 1998).
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elements
Cis-regulatory sequences included in the 12.5-kb transgene
were sufficient for expression in embryonic duodenal and
stomach endoderm but not in the mature organs. Deletion of
Area I-II-III, the only highly conserved noncoding sequence
present in the 12.5-kb transgene, mildly reduced expression in
both embryonic and mature gut tissues (Fujitani et al., 2006).
These results suggest that proximal and distal promoter
elements cooperatively promote expression of Pdx1 in the
posterior foregut. In the embryonic duodenum and stomach,
lack of either proximal or distal cis-regulatory elements can be
compensated by the remaining regulatory regions. In the
postnatal gut, however, distal regulatory regions appear to be
more important than proximal elements for maintenance of
Pdx1 expression. Review of previously characterized transacti-
vator-binding motifs in the 5′ Pdx1 locus (Fig. 10) reveals
several binding sites for the Foxa and Hnf factors, which are
broadly expressed in early endoderm, in both the proximal and
distal promoter regions. The presence of multiple binding sites
for these factors may explain the maintenance of at least basal
levels of Pdx1 expression throughout the embryonic posterior
foregut when either proximal or distal 5′ sequences are
removed.
Several binding sites for factors enriched in pancreatic
endocrine cells are found within Areas I and II, which may
account for the strong pancreatic phenotype of Area I-II-III
deletion mutants (Fujitani et al., 2006). Pax6 and MafA
binding in Area II may be particularly important for
expression of Pdx1 in β cells (Samaras et al., 2002,
2003). Based on the results of the current study, it seems
likely that there is a cis-regulatory activity in the distal 5′
region that is important for Pdx1 transcription in duodenal
crypt stem cells, an activity that cannot readily be
accounted for by previously characterized transactivator
binding interactions.
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